Fair enough, I personally know people who have had herpes before, doctor has told them it's fine if it reappears to use some cream and that's been the end of it.
Something most don't take into consideration when estimating the potential market for herpes is not how many people have it, but how many are actually aware and how many care to do something about it when they do get it. Price and convenience will also obviously plays a large factor when dealing with these type health issues.
- Forums
- ASX - By Stock
- AVR
- 2:1000000 million chance of getting brain damage from Herpes
2:1000000 million chance of getting brain damage from Herpes, page-8
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$9.00 |
Change
0.200(2.27%) |
Mkt cap ! $190.2M |
Open | High | Low | Value | Volume |
$8.90 | $9.48 | $8.88 | $176.7K | 19.75K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 590 | $8.80 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$9.40 | 70 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 590 | 8.800 |
2 | 2067 | 8.680 |
1 | 260 | 8.510 |
1 | 300 | 8.500 |
1 | 2 | 8.420 |
Price($) | Vol. | No. |
---|---|---|
9.400 | 70 | 1 |
9.430 | 105 | 1 |
9.490 | 218 | 1 |
9.500 | 250 | 1 |
9.850 | 1000 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online